EUVIMEDEUVIMED entdecken
Scoping Review

COVID-19 and vascular access: Evidence and lessons for improving the standard of care, a scoping review

Rosita Celano, Francesco Urso, Arianna Bartoli, Alessia Meschia, Matteo Maria Masseroli, Federica Cirigliano, Marta Colaneri, Antonella Foschi, Andrea Gori, Chiara Cogliati, Maria Calloni, Alba Taino und 3 weitere

The Journal of Vascular Access · 2026

DOI: 10.1177/11297298251398421 ↗

Kurz gefasst

Scoping Review in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Rosita Celano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences, University of Milan and Internal Medicine, Luigi Sacco Hospital, ASST-Fbf-Sacco, Milan, Italy. Hauptthemen laut MEDLINE: COVID-19, Catheterization, Central Venous, Catheter-Related Infections, Catheterization, Peripheral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 128 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Coronavirus Disease 2019 (COVID-19) pandemic has significantly impacted intravenous therapy practices, particularly in critically ill patients. Vascular access strategies were adapted to evolving clinical needs, infection control priorities, and resource limitations, with a focus on safety, efficacy, and technological advancements. This scoping review aimed to explore how the COVID-19 pandemic affected vascular access practices and catheter-related complications, with the objective of mapping innovations, identifying emerging trends, and summarizing preventive and therapeutic strategies. The review followed PRISMA-ScR guidelines and was registered in PROSPERO (CRD420251027530). A systematic search was conducted in PubMed ® , EMBASE ® , EBSCO-CINAHL ® , and CENTRAL for English-language studies published between January 2020 and May 2025 addressing catheter-related complications in COVID-19 patients, including catheter-related bloodstream infections (CRBSI), central line-associated bloodstream infections (CLABSI), catheter-related thrombosis (CRT), and accidental catheter removal. Among 521 screened articles, 58 met the inclusion criteria. Most studies reported higher rates of CRBSI, CLABSI, CRT, and accidental removal in COVID-19 patients, especially in critical care settings. Arterial catheters were also associated with elevated risks of thrombosis and infection during the pandemic. Mid-thigh femoral access sites emerged as practical alternatives to reduce central line use and healthcare personnel exposure. Technological advances, including power-injectable catheters, ultrasound-guided insertion, intracavitary ECG for tip confirmation, and securement tools such as cyanoacrylate glue and subcutaneous anchor systems, improved safety and reduced mechanical and infectious complications. Chlorhexidine-based antisepsis, antimicrobial-impregnated devices, and disinfectant caps effectively decreased CRBSI and CLABSI rates. In older, comorbid patients—now representing the majority of COVID-19 hospitalizations—nutritional and anticoagulant therapy must be carefully balanced to minimize bleeding and thrombotic risks. In conclusion, the pandemic catalyzed significant innovation and adaptation in vascular access practices. Integrating portable technologies, infection prevention strategies, and alternative access routes has enhanced patient care and established new standards for managing intravenous therapy in high-risk, resource-constrained settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Catheterization, Central VenousCatheter-Related InfectionsCatheterization, PeripheralInfection ControlHumansRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

COVID-19catheter-related bloodstream infectioncatheter-related thrombosiscentral line-associated bloodstream infectioncentrally inserted central cathetersfemoral-inserted central catheterslong peripheral cathetersmidline catheterperipherally inserted central cathetersvascular access

Autor:innen und Institutionen

  • Department of Biomedical and Clinical Sciences, University of Milan and Internal Medicine, Luigi Sacco Hospital, ASST-Fbf-Sacco, Milan, Italy.
  • Unit II, Department of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
  • Infectious Diseases Unit, Catholic University Hospital "A. Gemelli," Rome, Italy.
  • Department of Surgery, Fondazione Policlinico Universitario "A. Gemelli," Rome, Italy.

ORCID-Profile: Mauro Pittiruti, Antonio Gidaro

Zitieren

APA

Celano, R., Urso, F., Bartoli, A., Meschia, A., Masseroli, M. M., Cirigliano, F., Colaneri, M., Foschi, A., Gori, A., Cogliati, C., Calloni, M., Taino, A., Scoppettuolo, G., Pittiruti, M., & Gidaro, A. (2026). COVID-19 and vascular access: Evidence and lessons for improving the standard of care, a scoping review. The Journal of Vascular Access. https://doi.org/10.1177/11297298251398421

Vancouver

Celano R, Urso F, Bartoli A, Meschia A, Masseroli MM, Cirigliano F, et al. COVID-19 and vascular access: Evidence and lessons for improving the standard of care, a scoping review. The Journal of Vascular Access. 2026. doi:10.1177/11297298251398421

BibTeX
@article{Celano2026,
  author = {Celano, Rosita and Urso, Francesco and Bartoli, Arianna and Meschia, Alessia and Masseroli, Matteo Maria and Cirigliano, Federica and Colaneri, Marta and Foschi, Antonella and Gori, Andrea and Cogliati, Chiara and Calloni, Maria and Taino, Alba and Scoppettuolo, Giancarlo and Pittiruti, Mauro and Gidaro, Antonio},
  title = {COVID-19 and vascular access: Evidence and lessons for improving the standard of care, a scoping review},
  journal = {The Journal of Vascular Access},
  year = {2026},
  doi = {10.1177/11297298251398421}
}
Kostenlos starten →